Table 3 Age as per FDA-approved product label for drugs under study with such specification
From: Off-label use of cancer therapies in women diagnosed with breast cancer in the United States
Drug name | Labeled age (years) 1 |
|---|---|
Clofarabine | 1-21 |
Fluoxymesterone | ≤50 |
Goserelin | ≤50 |
Anastrozole | ≥50 |
Exemestane | ≥50 |
Fulvestrant | ≥50 |
Letrozole | ≥50 |
Gemtuzumab ozogamicin | ≥50 |